Cancer Communications
indexed by SCI
BMC

About the cover
About the cover

May 2015; Volume 34 Issue 5

May 1958, 5-fluorouracil (5-FU), a chemotherapy drug, was used to treat many cancers. It is a first-line treatment for colon cancer.


Original Article
Dosimetric benefit to organs at risk following margin reductions in nasopharyngeal carcinoma treated with intensity-modulated radiation therapy
Yan-Ping Mao, Wen-Jing Yin, Rui Guo, Guang-Shun Zhang, Jian-Lan Fang, Feng Chi, Zhen-Yu Qi, Meng-Zhong Liu, Jun Ma and Ying Sun
[ Abstract  1331]  [ PDF Full-text  1542]   [ HTML Full-text  760]    Epub: 2015-5-20  doi: 10.1186/s40880-015-0016-8
Spatio-temporal analysis of female breast cancer incidence in Shenzhen, 2007–2012
Hai-Bin Zhou, Sheng-Yuan Liu, Lin Lei, Zhong-Wei Chen, Ji Peng, Ying-Zhou Yang and Xiao-Li Liu
[ Abstract  1473]  [ PDF Full-text  1692]   [ HTML Full-text  1258]    Epub: 2015-5-14  doi: 10.1186/s40880-015-0013-y
Impact of oral anti–hepatitis B therapy on the survival of patients with hepatocellular carcinoma initially treated with chemoembolization
Zhong-Guo Zhou, Xing-Rong Zheng, Qian Zhou, Ming Shi, Yao-Jun Zhang, Rong-Ping Guo, Yun-Fei Yuan, Min-Shan Chen, Xiao-Jun Lin, Xiang-Ming Lao and Sheng-Ping Li
[ Abstract  1249]  [ PDF Full-text  2093]   [ HTML Full-text  746]    Epub: 2015-5-14  doi: 10.1186/s40880-015-0017-7
Hepatocellular adenoma with malignant transformation in male patients with non-cirrhotic livers
Song-Lin An, Li-Ming Wang, Wei-Qi Rong, Fan Wu, Wei Sun, Wei-Bo Yu, Li Feng, Fa-Qiang Liu, Fei Tian and Jian-Xiong Wu
[ Abstract  1322]  [ PDF Full-text  1653]   [ HTML Full-text  820]    Epub: 2015-5-24  doi: 10.1186/s40880-015-0014-x
Hepatitis B virus reactivation and hepatitis in diffuse large B-cell lymphoma patients with resolved hepatitis B receiving rituximab-containing chemotherapy: risk factors and survival
Kai-Lin Chen, Jie Chen, Hui-Lan Rao, Ying Guo, Hui-Qiang Huang, Liang Zhang, Jian-Yong Shao, Tong-Yu Lin, Wen-Qi Jiang, De-Hui Zou, Li-Yang Hu, Michael Lucas Wirian and Qing-Qing Cai
[ Abstract  2175]  [ PDF Full-text  3207]   [ HTML Full-text  1300]    Epub: 2015-5-28  doi: 10.1186/s40880-015-0015-9




CJC Wechat 微信公众号

CJC触屏版


 

Editorial Manager


CC adopts Editorial Manager to manage its submissions from Dec.18, 2014
 

 

Reference style for  

 EndNote,
 Reference Manager



Editorial Manager


 

Year:

 

Month:

Advanced search

Subscription


CJC is now published by BioMed Central

© Chinese Journal of Cancer

Sun Yat-sen University Cancer Center

651 Dongfeng Road East, Guangzhou 510060, P. R. China